COMMUNIQUÉS West-GlobeNewswire

Middlesex Recovery Earns Three-Year CARF Accreditation
12/03/2024
LEWISVILLE, Texas, March 12, 2024 (GLOBE NEWSWIRE) -- Middlesex Recovery is proud to announce that it has earned a Three-Year Accreditation from the Commission on Accreditation of Rehabilitation Facilities (CARF) for [...]
EverythingALS Launches the Vision 2030 AI Hub: Charting the Path to an ALS Cure and Advancing Neurodegenerative Disease Research
12/03/2024
Vision 2030 will utilize advanced technologies and an innovative operating model for research and drug development SAN FRANCISCO, March 12, 2024 (GLOBE NEWSWIRE) -- EverythingALS, a leading force in the fight against [...]
Health-ISAC Supports Health Industry Cybersecurity Strategic Plan
12/03/2024
Joint effort gives measurable objectives toward resilience within 5 years ORMOND BEACH, Fla., March 12, 2024 (GLOBE NEWSWIRE) -- Health-ISAC, a non-profit, member driven organization is pleased to contribute to the [...]
Love for Liam Foundation to Host the Third Annual Liam Johnson Memorial Golf Outing & Benefit Dinner on May 10, 2024
12/03/2024
PHILADELPHIA, March 12, 2024 (GLOBE NEWSWIRE) -- The Love for Liam Foundation , a 501(c)(3) nonprofit that seeks to raise awareness for pediatric epilepsy and drive research funding, today announced its Third Annual [...]
Healthcare Triangle, Inc. Appoints Anand Kumar as Interim CEO
12/03/2024
PLEASANTON, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Healthcare Triangle Inc. (Nasdaq: HCTI) (“Healthcare Triangle,” “HCTI” or the “Company”), a frontrunner in healthcare technology has announced the appointment of [...]
Eupraxia Pharmaceuticals Announces Pricing of Overnight Marketed Offering of $30 Million
12/03/2024
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VICTORIA, British Columbia, March 12, 2024 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a [...]
GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY
12/03/2024
Rutherford, NJ, March 12, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization of novel [...]
Celularity CEO to Present Keynote Address at 2024 Society for Brain Mapping and Therapeutics Annual World Congress
12/03/2024
Keynote Will Discuss Cellular Immunotherapy’s Potential for Treating Chronic Conditions, Including Cancer, Multiple Sclerosis and Parkinson’s Disease FLORHAM PARK, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- Celularity Inc [...]
Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge
12/03/2024
ART26.12 Preclinical Dermatology Research Presented to the Immuno-dermatology Leadership Team at Johnson & Johnson SOLANA BEACH, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a [...]
Sharecare provides strategic update
12/03/2024
Independent special committee of the Sharecare Board of Directors reviewing multiple proposals ATLANTA, March 12, 2024 (GLOBE NEWSWIRE) -- Sharecare (Nasdaq: SHCR ) has been evaluating a range of options including a [...]
HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes
12/03/2024
Data Demonstrated MyoVista AI-ECG model significantly outperformed NT-proBNP and ARIC HF score, the conventional standards of care for Stage B Heart Failure screening Southlake, Texas, March 12, 2024 (GLOBE NEWSWIRE [...]
HeartFlow Announces Publication of 10-year Follow-Up Data from the DISCOVER-FLOW Study in the Journal of Cardiovascular Computed Tomography
12/03/2024
HeartFlow's non-invasive AI driven FFR CT predicts patient outcomes as effectively as the gold-standard invasive FFR out to 10 years MOUNTAIN VIEW, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- HeartFlow, Inc., a leader in [...]
T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement
12/03/2024
LEXINGTON, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that the Nasdaq [...]
Sharecare reschedules issuance of fourth quarter and full year 2023 earnings release and investor conference call
12/03/2024
ATLANTA, March 12, 2024 (GLOBE NEWSWIRE) -- Sharecare (Nasdaq: SHCR ), the digital health company that helps people manage all their health in one place, today announced that it has postponed the release of its [...]
MangoRx Officially Launches ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment
12/03/2024
The Dallas Based, Direct-to-Consumer Telemedicine Company Brings the FDA-Approved Oral Testosterone Replacement Therapy Treatment to the Telehealth Market Dallas, Texas, March 12, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals [...]
Arctic Therapeutics and Nacuity Pharmaceuticals Announce European Medicines Agency Approval to Initiate First Clinical Trial of AT-001 (NPI-001) for the Treatment of HCCAA
12/03/2024
EMA approved clinical trial of AT-001 (NPI-001) in Iceland REYKJAVIK, Iceland and FORT WORTH, Texas, March 12, 2024 (GLOBE NEWSWIRE) -- Arctic Therapeutics ehf, an Icelandic drug development company and partner Nacuity [...]
Solera and Aon Collaborate to Offer Employers Curated Network of Digital Health Solutions and Analytics for Clinical Outcomes and Cost Savings
12/03/2024
Collaboration provides personalized employee health experiences and optimized outcomes across the most common chronic conditions - delivering a streamlined solution PHOENIX, March 12, 2024 (GLOBE NEWSWIRE) -- Solera [...]
Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke
12/03/2024
-- Enrollment of at least ten patients at Brooks Rehabilitation will begin this month -- -- Study will evaluate the use of Portable Neuromodulation Stimulator (PoNS®) for gait and balance deficits in chronic stroke [...]
Nanox Announces AI Software Increases Identification of Patients with Vertebral Compression Fractures, an early sign of Osteoporosis, Up to Six-Fold
12/03/2024
– According to early findings in the ADOPT study, Nanox.AI software improves detection of key risk factor for osteoporosis, outperforming UK National Health Service national average – Findings demonstrate real-world [...]

Pages